| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acknowledgements
|
|
|
2012
|
30 |
Supplement 3 |
p. vii-
1 p.
|
artikel
|
| 2 |
Adenovirus-based vaccination against Clostridium difficile toxin A allows for rapid humoral immunity and complete protection from toxin A lethal challenge in mice
|
Seregin, Sergey S.
|
|
2012
|
30 |
Supplement 3 |
p. 1492-1501
10 p.
|
artikel
|
| 3 |
Adjuvant effect of Japanese herbal medicines on the mucosal type 1 immune responses to human papillomavirus (HPV) E7 in mice immunized orally with Lactobacillus-based therapeutic HPV vaccine in a synergistic manner
|
Taguchi, Ayumi
|
|
2012
|
30 |
Supplement 3 |
p. 5368-5372
5 p.
|
artikel
|
| 4 |
A dose-escalation safety and immunogenicity study of a new live attenuated human rotavirus vaccine (Rotavin-M1) in Vietnamese children
|
Anh, Dang Duc
|
|
2012
|
30 |
Supplement 3 |
p. A114-A121
nvt p.
|
artikel
|
| 5 |
Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010
|
Ouandaogo, Claude-Roger
|
|
2012
|
30 |
Supplement 3 |
p. B46-B51
nvt p.
|
artikel
|
| 6 |
A genome-wide association study of host genetic determinants of the antibody response to Anthrax Vaccine Adsorbed
|
Pajewski, Nicholas M.
|
|
2012
|
30 |
Supplement 3 |
p. 4778-4784
7 p.
|
artikel
|
| 7 |
An alternative signal 3: CD8+ T cell memory independent of IL-12 and type I IFN is dependent on CD27/OX40 signaling
|
Sanchez, Phillip J.
|
|
2012
|
30 |
Supplement 3 |
p. 1154-1161
8 p.
|
artikel
|
| 8 |
Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine
|
Breiman, Robert F.
|
|
2012
|
30 |
Supplement 3 |
p. A24-A29
nvt p.
|
artikel
|
| 9 |
An economic evaluation of the use of Japanese encephalitis vaccine in the expanded program of immunization of Guizhou province, China
|
Yin, Zundong
|
|
2012
|
30 |
Supplement 3 |
p. 5569-5577
9 p.
|
artikel
|
| 10 |
A non-adjuvanted whole-virus H1N1 pandemic vaccine is well tolerated and highly immunogenic in children and adolescents and induces substantial immunological memory
|
Loew-Baselli, Alexandra
|
|
2012
|
30 |
Supplement 3 |
p. 5956-5966
11 p.
|
artikel
|
| 11 |
An update on human papillomavirus vaccine uptake among 11–17 year old girls in the United States: National Health Interview Survey, 2010
|
Laz, Tabassum H.
|
|
2012
|
30 |
Supplement 3 |
p. 3534-3540
7 p.
|
artikel
|
| 12 |
A phase 3, randomized, double-blind trial comparing the safety and immunogenicity of the 7-valent and 13-valent pneumococcal conjugate vaccines, given with routine pediatric vaccinations, in healthy infants in Brazil
|
Weckx, Lily Yin
|
|
2012
|
30 |
Supplement 3 |
p. 7566-7572
7 p.
|
artikel
|
| 13 |
A possible relationship of natural killer T cells with humoral immune response to 23-valent pneumococcal polysaccharide vaccine in clinical settings
|
Miyasaka, Tomomitsu
|
|
2012
|
30 |
Supplement 3 |
p. 3304-3310
7 p.
|
artikel
|
| 14 |
A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 5 through 17 years of age
|
Baxter, Roger
|
|
2012
|
30 |
Supplement 3 |
p. 2989-2998
10 p.
|
artikel
|
| 15 |
A randomised, single-blind, dose-range study to assess the immunogenicity and safety of a cell-culture-derived A/H1N1 influenza vaccine in adult and elderly populations
|
Hatz, Christoph
|
|
2012
|
30 |
Supplement 3 |
p. 4820-4827
8 p.
|
artikel
|
| 16 |
A recombinant adenovirus expressing immunodominant TB antigens can significantly enhance BCG-induced human immunity
|
Hoft, Daniel F.
|
|
2012
|
30 |
Supplement 3 |
p. 2098-2108
11 p.
|
artikel
|
| 17 |
A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines
|
Schiller, John T.
|
|
2012
|
30 |
Supplement 3 |
p. F123-F138
nvt p.
|
artikel
|
| 18 |
A small animal peripheral challenge model of yellow fever using interferon-receptor deficient mice and the 17D-204 vaccine strain
|
Thibodeaux, Brett A.
|
|
2012
|
30 |
Supplement 3 |
p. 3180-3187
8 p.
|
artikel
|
| 19 |
Assessment of the cross-protective capability of recombinant capsid proteins derived from pig, rat, and avian hepatitis E viruses (HEV) against challenge with a genotype 3 HEV in pigs
|
Sanford, Brenton J.
|
|
2012
|
30 |
Supplement 3 |
p. 6249-6255
7 p.
|
artikel
|
| 20 |
A US postmarketing evaluation of the frequency and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years: 2009–2010 season
|
Tennis, Patricia
|
|
2012
|
30 |
Supplement 3 |
p. 6099-6102
4 p.
|
artikel
|
| 21 |
Avian paramyxovirus serotypes 2-9 (APMV-2-9) vary in the ability to induce protective immunity in chickens against challenge with virulent Newcastle disease virus (APMV-1)
|
Nayak, Baibaswata
|
|
2012
|
30 |
Supplement 3 |
p. 2220-2227
8 p.
|
artikel
|
| 22 |
Barriers to HPV immunization for African American adolescent females
|
Hamlish, Tamara
|
|
2012
|
30 |
Supplement 3 |
p. 6472-6476
5 p.
|
artikel
|
| 23 |
Baseline hepatitis B vaccination coverage among persons with diabetes before implementing a U.S. recommendation for vaccination
|
Byrd, Kathy K.
|
|
2012
|
30 |
Supplement 3 |
p. 3376-3382
7 p.
|
artikel
|
| 24 |
Birth order and private voluntary immunization—A study of 110,902 children
|
Gavrielov-Yusim, Natalie
|
|
2012
|
30 |
Supplement 3 |
p. 442-447
6 p.
|
artikel
|
| 25 |
Bovine tuberculosis vaccine research: Historical perspectives and recent advances
|
Waters, W. Ray
|
|
2012
|
30 |
Supplement 3 |
p. 2611-2622
12 p.
|
artikel
|
| 26 |
Broad antibody and T cell reactivity induced by a pneumococcal whole-cell vaccine
|
Moffitt, Kristin L.
|
|
2012
|
30 |
Supplement 3 |
p. 4316-4322
7 p.
|
artikel
|
| 27 |
Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS)
|
Loughlin, Anita M.
|
|
2012
|
30 |
Supplement 3 |
p. 7253-7259
7 p.
|
artikel
|
| 28 |
Cell-mediated immune responses to a varicella-zoster virus glycoprotein E vaccine using both a TLR agonist and QS21 in mice
|
Dendouga, Najoua
|
|
2012
|
30 |
Supplement 3 |
p. 3126-3135
10 p.
|
artikel
|
| 29 |
Challenge with a hepatitis B vaccine in two cohorts of 4–7-year-old children primed with hexavalent vaccines: An open-label, randomised trial in Italy
|
Zanetti, Alessandro
|
|
2012
|
30 |
Supplement 3 |
p. 5770-5775
6 p.
|
artikel
|
| 30 |
Characterisation of vaccine-induced, broadly cross-reactive IFN-γ secreting T cell responses that correlate with rapid protection against classical swine fever virus
|
Graham, Simon P.
|
|
2012
|
30 |
Supplement 3 |
p. 2742-2748
7 p.
|
artikel
|
| 31 |
Characteristics of serology-based vaccine potency models for foot-and-mouth disease virus
|
Willems, Tom
|
|
2012
|
30 |
Supplement 3 |
p. 5849-5855
7 p.
|
artikel
|
| 32 |
Characterizing providers’ immunization communication practices during health supervision visits with vaccine-hesitant parents: A pilot study
|
Opel, Douglas J.
|
|
2012
|
30 |
Supplement 3 |
p. 1269-1275
7 p.
|
artikel
|
| 33 |
Chemotypical variations in Withania somnifera lead to differentially modulated immune response in BALB/c mice
|
Kushwaha, Susheela
|
|
2012
|
30 |
Supplement 3 |
p. 1083-1093
11 p.
|
artikel
|
| 34 |
Colostrum from cattle immunized with a vaccine based on iron regulated proteins of Mannheimia haemolytica confers partial protection
|
Makoschey, B.
|
|
2012
|
30 |
Supplement 3 |
p. 969-973
5 p.
|
artikel
|
| 35 |
Combination vaccines in the South African setting
|
Visser, Adele
|
|
2012
|
30 |
Supplement 3 |
p. C38-C44
nvt p.
|
artikel
|
| 36 |
Comparative immunogenicity and safety of different multivalent component pertussis vaccine formulations and a 5-component acellular pertussis vaccine in infants and toddlers: A randomized, controlled, open-label, multicenter study
|
Chatterjee, Archana
|
|
2012
|
30 |
Supplement 3 |
p. 3360-3368
9 p.
|
artikel
|
| 37 |
Conjugation of Y. pestis F1-antigen to gold nanoparticles improves immunogenicity
|
Gregory, A.E.
|
|
2012
|
30 |
Supplement 3 |
p. 6777-6782
6 p.
|
artikel
|
| 38 |
Construction and immune effect of Haemophilus parasuis DNA vaccine encoding glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in mice
|
Fu, Shulin
|
|
2012
|
30 |
Supplement 3 |
p. 6839-6844
6 p.
|
artikel
|
| 39 |
Cost-effectiveness of potential infant vaccination against respiratory syncytial virus infection in The Netherlands
|
Meijboom, M.J.
|
|
2012
|
30 |
Supplement 3 |
p. 4691-4700
10 p.
|
artikel
|
| 40 |
Current issues with the immunization program in Japan: Can we fill the “vaccine gap”?
|
Saitoh, Akihiko
|
|
2012
|
30 |
Supplement 3 |
p. 4752-4756
5 p.
|
artikel
|
| 41 |
Design and immunological properties of Helicobacter pylori glycoconjugates based on a truncated lipopolysaccharide lacking Lewis antigen and comprising an α-1,6-glucan chain
|
Altman, Eleonora
|
|
2012
|
30 |
Supplement 3 |
p. 7332-7341
10 p.
|
artikel
|
| 42 |
Development of sipuleucel-T: Autologous cellular immunotherapy for the treatment of metastatic castrate resistant prostate cancer
|
Sims, Robert B.
|
|
2012
|
30 |
Supplement 3 |
p. 4394-4397
4 p.
|
artikel
|
| 43 |
Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response
|
Taylor, David N.
|
|
2012
|
30 |
Supplement 3 |
p. 5761-5769
9 p.
|
artikel
|
| 44 |
Direct and indirect impact of influenza vaccination of young children on school absenteeism
|
King Jr., James C.
|
|
2012
|
30 |
Supplement 3 |
p. 289-293
5 p.
|
artikel
|
| 45 |
Early infection dynamics after experimental challenge with Mycobacterium avium subspecies paratuberculosis in calves reveal limited calf-to-calf transmission and no impact of Hsp70 vaccination
|
Santema, Wiebren J.
|
|
2012
|
30 |
Supplement 3 |
p. 7032-7039
8 p.
|
artikel
|
| 46 |
Economic analysis for evidence-based policy-making on a national immunization program: A case of rotavirus vaccine in Thailand
|
Muangchana, Charung
|
|
2012
|
30 |
Supplement 3 |
p. 2839-2847
9 p.
|
artikel
|
| 47 |
Economic evaluation of vaccination programme of 7-valent pneumococcal conjugate vaccine to the birth cohort in Japan
|
Hoshi, Shu-ling
|
|
2012
|
30 |
Supplement 3 |
p. 3320-3328
9 p.
|
artikel
|
| 48 |
Editorial Board
|
|
|
2012
|
30 |
Supplement 3 |
p. CO2-
1 p.
|
artikel
|
| 49 |
Editorial Board
|
|
|
2011
|
30 |
Supplement 3 |
p. CO2-
1 p.
|
artikel
|
| 50 |
Editorial Board
|
|
|
2012
|
30 |
Supplement 3 |
p. CO2-
1 p.
|
artikel
|
| 51 |
Editorial Board
|
|
|
2012
|
30 |
Supplement 3 |
p. CO2-
1 p.
|
artikel
|
| 52 |
Editorial Board/Aims and Scope
|
|
|
2012
|
30 |
Supplement 3 |
p. CO2-
1 p.
|
artikel
|
| 53 |
Effectively introducing a new meningococcal A conjugate vaccine in Africa: The Burkina Faso experience
|
Djingarey, Mamoudou H.
|
|
2012
|
30 |
Supplement 3 |
p. B40-B45
nvt p.
|
artikel
|
| 54 |
Effectiveness of rotavirus vaccines in preventing cases and hospitalizations due to rotavirus gastroenteritis in Navarre, Spain
|
Castilla, Jesús
|
|
2012
|
30 |
Supplement 3 |
p. 539-543
5 p.
|
artikel
|
| 55 |
Effects of immunization with natural and recombinant lysine decarboxylase on canine gingivitis development
|
Peters, Jennifer L.
|
|
2012
|
30 |
Supplement 3 |
p. 6706-6712
7 p.
|
artikel
|
| 56 |
Efficacy of an AS03A-adjuvanted split H5N1 influenza vaccine against an antigenically distinct low pathogenic H5N1 virus in pigs
|
De Vleeschauwer, Annebel R.
|
|
2012
|
30 |
Supplement 3 |
p. 5557-5563
7 p.
|
artikel
|
| 57 |
Efficacy of a reformulated inactivated chimeric PCV1-2 vaccine based on clinical, virological, pathological and immunological examination under field conditions
|
Seo, Hwi Won
|
|
2012
|
30 |
Supplement 3 |
p. 6671-6677
7 p.
|
artikel
|
| 58 |
Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: A randomized, double-blind, placebo controlled trial
|
Cunliffe, Nigel A.
|
|
2012
|
30 |
Supplement 3 |
p. A36-A43
nvt p.
|
artikel
|
| 59 |
Efficacy of pentavalent rotavirus vaccine in a high HIV prevalence population in Kenya
|
Feikin, Daniel R.
|
|
2012
|
30 |
Supplement 3 |
p. A52-A60
nvt p.
|
artikel
|
| 60 |
Efficacy of the oral pentavalent rotavirus vaccine in Mali
|
Sow, Samba O.
|
|
2012
|
30 |
Supplement 3 |
p. A71-A78
nvt p.
|
artikel
|
| 61 |
Efficient extraction of vaccines formulated in aluminum hydroxide gel by including surfactants in the extraction buffer
|
Zhu, Daming
|
|
2012
|
30 |
Supplement 3 |
p. 189-194
6 p.
|
artikel
|
| 62 |
Eliciting broad neutralizing antibody to HIV-1: Envelopes of different lentivirus cross immunization by prime-boost vaccination
|
Luo, Zhenwu
|
|
2012
|
30 |
Supplement 3 |
p. 5316-5323
8 p.
|
artikel
|
| 63 |
Estimating pandemic vaccine effectiveness in two Italian regions using the screening method, 2009–2010
|
Seyler, Thomas
|
|
2012
|
30 |
Supplement 3 |
p. 109-111
3 p.
|
artikel
|
| 64 |
Estimating the age-specific duration of herpes zoster vaccine protection: A matter of model choice?
|
Bilcke, Joke
|
|
2012
|
30 |
Supplement 3 |
p. 2795-2800
6 p.
|
artikel
|
| 65 |
Evaluating associations between sources of information, knowledge of the human papillomavirus, and human papillomavirus vaccine uptake for adult women in California
|
Almeida, Cristina M.
|
|
2012
|
30 |
Supplement 3 |
p. 3003-3008
6 p.
|
artikel
|
| 66 |
Evaluation of a toolkit to introduce standing orders for influenza and pneumococcal vaccination in adults: A multimodal pilot project
|
Nowalk, Mary Patricia
|
|
2012
|
30 |
Supplement 3 |
p. 5978-5982
5 p.
|
artikel
|
| 67 |
Evaluation of meningococcal serogroup C conjugate vaccine programs in Canadian children: Interim analysis
|
Bettinger, Julie A.
|
|
2012
|
30 |
Supplement 3 |
p. 4023-4027
5 p.
|
artikel
|
| 68 |
Evaluation of protective effect of DNA vaccines encoding the BAB1_0263 and BAB1_0278 open reading frames of Brucella abortus in BALB/c mice
|
Sislema-Egas, Fernanda
|
|
2012
|
30 |
Supplement 3 |
p. 7286-7291
6 p.
|
artikel
|
| 69 |
Evaluation of the humoral immune response in adult dairy cattle three years after vaccination with a bluetongue serotype 8 inactivated vaccine
|
Oura, C.A.L.
|
|
2012
|
30 |
Supplement 3 |
p. 112-115
4 p.
|
artikel
|
| 70 |
Evaluation of two chimeric bovine-human parainfluenza virus type 3 vaccines in infants and young children
|
Karron, Ruth A.
|
|
2012
|
30 |
Supplement 3 |
p. 3975-3981
7 p.
|
artikel
|
| 71 |
Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
|
Arbyn, Marc
|
|
2012
|
30 |
Supplement 3 |
p. F88-F99
nvt p.
|
artikel
|
| 72 |
Factors associated with HPV vaccine uptake in teenage girls: A systematic review
|
Kessels, Sharon J.M.
|
|
2012
|
30 |
Supplement 3 |
p. 3546-3556
11 p.
|
artikel
|
| 73 |
Factors influencing pandemic influenza vaccination of healthcare workers—A systematic review
|
Prematunge, Chatura
|
|
2012
|
30 |
Supplement 3 |
p. 4733-4743
11 p.
|
artikel
|
| 74 |
Feasibility of a randomized controlled trial to evaluate Text Reminders for Immunization Compliance in Kids (TRICKs)
|
Ahlers-Schmidt, Carolyn R.
|
|
2012
|
30 |
Supplement 3 |
p. 5305-5309
5 p.
|
artikel
|
| 75 |
Flaviviruses and flavivirus vaccines
|
Heinz, Franz X.
|
|
2012
|
30 |
Supplement 3 |
p. 4301-4306
6 p.
|
artikel
|
| 76 |
Formulation and evaluation of oral microparticulate ovarian cancer vaccines
|
Tawde, Suprita A.
|
|
2012
|
30 |
Supplement 3 |
p. 5675-5681
7 p.
|
artikel
|
| 77 |
Ginsenosides Rg1 and Re act as adjuvant via TLR4 signaling pathway
|
Su, Fei
|
|
2012
|
30 |
Supplement 3 |
p. 4106-4112
7 p.
|
artikel
|
| 78 |
Global Burden of Human Papillomavirus and Related Diseases
|
Forman, David
|
|
2012
|
30 |
Supplement 3 |
p. F12-F23
nvt p.
|
artikel
|
| 79 |
Health economics of rotavirus immunization in Vietnam: Potentials for favorable cost-effectiveness in developing countries
|
Tu, Hong-Anh T.
|
|
2012
|
30 |
Supplement 3 |
p. 1521-1528
8 p.
|
artikel
|
| 80 |
Heteroclitic peptides enhance human immunodeficiency virus-specific CD8+ T cell responses
|
Gladney, Krista H.
|
|
2012
|
30 |
Supplement 3 |
p. 6997-7004
8 p.
|
artikel
|
| 81 |
Homologous whole bacterin vaccination is not able to reduce Streptococcus suis serotype 9 strain 7997 transmission among pigs or colonization
|
Dekker, C.N.T.
|
|
2012
|
30 |
Supplement 3 |
p. 1379-1387
9 p.
|
artikel
|
| 82 |
Host immune response to A(H1N1)pdm09 vaccination and infection: A one-year prospective study on six cohorts of subjects
|
Liu, Wei
|
|
2012
|
30 |
Supplement 3 |
p. 4785-4789
5 p.
|
artikel
|
| 83 |
Human monoclonal antibodies generated following vaccination with AVA provide neutralization by blocking furin cleavage but not by preventing oligomerization
|
Smith, Kenneth
|
|
2012
|
30 |
Supplement 3 |
p. 4276-4283
8 p.
|
artikel
|
| 84 |
Human Papillomavirus Vaccine Introduction – The First Five Years
|
Markowitz, Lauri E.
|
|
2012
|
30 |
Supplement 3 |
p. F139-F148
nvt p.
|
artikel
|
| 85 |
Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine
|
Tomovici, A.
|
|
2012
|
30 |
Supplement 3 |
p. 2647-2653
7 p.
|
artikel
|
| 86 |
Immunity to tetanus and diphtheria in the UK in 2009
|
Wagner, Karen S.
|
|
2012
|
30 |
Supplement 3 |
p. 7111-7117
7 p.
|
artikel
|
| 87 |
Immunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 mice
|
Brewoo, Joseph N.
|
|
2012
|
30 |
Supplement 3 |
p. 1513-1520
8 p.
|
artikel
|
| 88 |
Immunogenicity and protective efficacy of a vaxfectin-adjuvanted tetravalent dengue DNA vaccine
|
Porter, Kevin R.
|
|
2012
|
30 |
Supplement 3 |
p. 336-341
6 p.
|
artikel
|
| 89 |
Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine administered concomitantly with measles, mumps, rubella, varicella vaccine in healthy toddlers
|
Klein, Nicola P.
|
|
2012
|
30 |
Supplement 3 |
p. 3929-3936
8 p.
|
artikel
|
| 90 |
Immunogenicity and safety of a two-dose regimen of a combined measles, mumps, rubella and varicella live vaccine (ProQuad®) in infants from 9 months of age
|
Vesikari, Timo
|
|
2012
|
30 |
Supplement 3 |
p. 3082-3089
8 p.
|
artikel
|
| 91 |
Immunogenicity and safety of tetravalent dengue vaccine in 2–11 year-olds previously vaccinated against yellow fever: Randomized, controlled, phase II study in Piura, Peru
|
Lanata, Claudio F.
|
|
2012
|
30 |
Supplement 3 |
p. 5935-5941
7 p.
|
artikel
|
| 92 |
Immunogenicity of Infanrix™ hexa administered at 3, 5 and 11 months of age
|
Van Der Meeren, Olivier
|
|
2012
|
30 |
Supplement 3 |
p. 2710-2714
5 p.
|
artikel
|
| 93 |
Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine
|
Woolpert, Tabitha
|
|
2012
|
30 |
Supplement 3 |
p. 3090-3096
7 p.
|
artikel
|
| 94 |
Immunogenicity of the pentavalent rotavirus vaccine among infants in two developing countries in Asia, Bangladesh and Vietnam
|
Shin, Sunheang
|
|
2012
|
30 |
Supplement 3 |
p. A106-A113
nvt p.
|
artikel
|
| 95 |
Immunogenicity of the pentavalent rotavirus vaccine in African infants
|
Armah, George E.
|
|
2012
|
30 |
Supplement 3 |
p. A86-A93
nvt p.
|
artikel
|
| 96 |
Immunogenicity, safety and tolerability of MF59-adjuvanted seasonal influenza vaccine in children with juvenile idiopathic arthritis
|
Dell’Era, Laura
|
|
2012
|
30 |
Supplement 3 |
p. 936-940
5 p.
|
artikel
|
| 97 |
Immunological impact of an additional early measles vaccine in Gambian children: Responses to a boost at 3 years
|
Njie-Jobe, Jainaba
|
|
2012
|
30 |
Supplement 3 |
p. 2543-2550
8 p.
|
artikel
|
| 98 |
Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales
|
Andrews, Nick J.
|
|
2012
|
30 |
Supplement 3 |
p. 6802-6808
7 p.
|
artikel
|
| 99 |
Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: An overview from Kuwait
|
Mokaddas, Eiman
|
|
2012
|
30 |
Supplement 3 |
p. G37-G40
nvt p.
|
artikel
|
| 100 |
Impact of pneumococcal vaccination in Denmark during the first 3 years after PCV introduction in the childhood immunization programme
|
Ingels, Helene
|
|
2012
|
30 |
Supplement 3 |
p. 3944-3950
7 p.
|
artikel
|
| 101 |
Impact of postpartum information about pertussis booster to parents in a university maternity hospital
|
Leboucher, Bertrand
|
|
2012
|
30 |
Supplement 3 |
p. 5472-5481
10 p.
|
artikel
|
| 102 |
Impact on disease incidence of a routine universal and catch-up vaccination strategy against Neisseria meningitidis C in Tuscany, Italy
|
Bechini, Angela
|
|
2012
|
30 |
Supplement 3 |
p. 6396-6401
6 p.
|
artikel
|
| 103 |
Implementation of a hepatitis A/B vaccination program using an accelerated schedule among high-risk inmates, Los Angeles County Jail, 2007–2010
|
Costumbrado, John
|
|
2012
|
30 |
Supplement 3 |
p. 6878-6882
5 p.
|
artikel
|
| 104 |
Inactivated HSV-2 in MPL/alum adjuvant provides nearly complete protection against genital infection and shedding following long term challenge and rechallenge
|
Morello, Christopher S.
|
|
2012
|
30 |
Supplement 3 |
p. 6541-6550
10 p.
|
artikel
|
| 105 |
Inactivated PCV2 one shot vaccine applied in 3-week-old piglets: Improvement of production parameters and interaction with maternally derived immunity
|
Fraile, Lorenzo
|
|
2012
|
30 |
Supplement 3 |
p. 1986-1992
7 p.
|
artikel
|
| 106 |
Inclusion of a CRF01_AE HIV envelope protein boost with a DNA/MVA prime-boost vaccine: Impact on humoral and cellular immunogenicity and viral load reduction after SHIV-E challenge
|
Cox, Josephine H.
|
|
2012
|
30 |
Supplement 3 |
p. 1830-1840
11 p.
|
artikel
|
| 107 |
International collaborative proficiency study of Human Papillomavirus type 16 serology
|
Eklund, Carina
|
|
2012
|
30 |
Supplement 3 |
p. 294-299
6 p.
|
artikel
|
| 108 |
Intrinsic adjuvanting of a novel single-cycle flavivirus vaccine in the absence of type I interferon receptor signaling
|
Winkelmann, Evandro R.
|
|
2012
|
30 |
Supplement 3 |
p. 1465-1475
11 p.
|
artikel
|
| 109 |
Introduction of silent mutations into the NP gene of influenza A viruses as a possible strategy for the creation of a live attenuated vaccine
|
Anhlan, Darisuren
|
|
2012
|
30 |
Supplement 3 |
p. 4480-4489
10 p.
|
artikel
|
| 110 |
In vitro derivation of interferon-γ producing, IL-4 and IL-7 responsive memory-like CD4+ T cells
|
Comber, Joseph D.
|
|
2012
|
30 |
Supplement 3 |
p. 2140-2145
6 p.
|
artikel
|
| 111 |
Isolation of influenza viruses in MDCK 33016PF cells and clearance of contaminating respiratory viruses
|
Roth, Bernhard
|
|
2012
|
30 |
Supplement 3 |
p. 517-522
6 p.
|
artikel
|
| 112 |
Lack of association between childhood immunizations and encephalitis in California, 1998–2008
|
Pahud, Barbara A.
|
|
2012
|
30 |
Supplement 3 |
p. 247-253
7 p.
|
artikel
|
| 113 |
Liposomal SLA co-incorporated with PO CpG ODNs or PS CpG ODNs induce the same protection against the murine model of leishmaniasis
|
Shargh, Vahid Heravi
|
|
2012
|
30 |
Supplement 3 |
p. 3957-3964
8 p.
|
artikel
|
| 114 |
Long-term efficacy of 10–12 years after being immunized with Chinese hamster ovary cell derived hepatitis B vaccine in Chinese Rural Communities
|
Wang, Feng
|
|
2012
|
30 |
Supplement 3 |
p. 2051-2053
3 p.
|
artikel
|
| 115 |
Malnutrition levels among vaccinated and unvaccinated children between 2 and 3 years of age following enrollment in a randomized clinical trial with the pentavalent rotavirus vaccine (PRV) in Bangladesh
|
Feller, Andrea J.
|
|
2012
|
30 |
Supplement 3 |
p. A101-A105
nvt p.
|
artikel
|
| 116 |
Maternal knowledge, attitudes and beliefs regarding gastroenteritis and rotavirus vaccine before implementing vaccination program: Which key messages in light of a new immunization program?
|
Morin, Alyssa
|
|
2012
|
30 |
Supplement 3 |
p. 5921-5927
7 p.
|
artikel
|
| 117 |
Measles, mumps, and rubella virus vaccine (M–M–R™II): A review of 32 years of clinical and postmarketing experience
|
Lievano, Fabio
|
|
2012
|
30 |
Supplement 3 |
p. 6918-6926
9 p.
|
artikel
|
| 118 |
Measuring bovine viral diarrhea virus vaccine response: Using a commercially available ELISA as a surrogate for serum neutralization assays
|
Gonda, M.G.
|
|
2012
|
30 |
Supplement 3 |
p. 6559-6563
5 p.
|
artikel
|
| 119 |
Methodology and lessons-learned from the efficacy clinical trial of the pentavalent rotavirus vaccine in Bangladesh
|
Zaman, K.
|
|
2012
|
30 |
Supplement 3 |
p. A94-A100
nvt p.
|
artikel
|
| 120 |
Molecular epidemiology of circulating highly pathogenic avian influenza (H5N1) virus in chickens, in Bangladesh, 2007–2010
|
Ahmed, Syed Sayeem Uddin
|
|
2012
|
30 |
Supplement 3 |
p. 7381-7390
10 p.
|
artikel
|
| 121 |
Motif-optimized subtype A HIV envelope-based DNA vaccines rapidly elicit neutralizing antibodies when delivered sequentially
|
Pissani, Franco
|
|
2012
|
30 |
Supplement 3 |
p. 5519-5526
8 p.
|
artikel
|
| 122 |
Mucosal vaccination increases local chemokine production attracting immune cells to the stomach mucosa of Helicobacter pylori infected mice
|
Flach, Carl-Fredrik
|
|
2012
|
30 |
Supplement 3 |
p. 1636-1643
8 p.
|
artikel
|
| 123 |
Multi-antigenic vaccine against the cattle tick Rhipicephalus (Boophilus) microplus: A field evaluation
|
Parizi, Luís F.
|
|
2012
|
30 |
Supplement 3 |
p. 6912-6917
6 p.
|
artikel
|
| 124 |
Multilevel correlates for human papillomavirus vaccination of adolescent girls attending safety net clinics
|
Tiro, Jasmin A.
|
|
2012
|
30 |
Supplement 3 |
p. 2368-2375
8 p.
|
artikel
|
| 125 |
NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults
|
Schmidt, Clint S.
|
|
2012
|
30 |
Supplement 3 |
p. 7594-7600
7 p.
|
artikel
|
| 126 |
Neonatal revaccination with Bacillus Calmette–Guérin elicits improved, early protection against Mycobacterium tuberculosis in mice
|
Li, Wen
|
|
2012
|
30 |
Supplement 3 |
p. 3223-3230
8 p.
|
artikel
|
| 127 |
Non-susceptibility trends and serotype coverage by conjugate pneumococcal vaccines in a Tunisian paediatric population: A 10-year study
|
Charfi, F.
|
|
2012
|
30 |
Supplement 3 |
p. G18-G24
nvt p.
|
artikel
|
| 128 |
Novel CD8+ T cell-based vaccine stimulates Gp120-specific CTL responses leading to therapeutic and long-term immunity in transgenic HLA-A2 mice
|
Nanjundappa, Roopa Hebbandi
|
|
2012
|
30 |
Supplement 3 |
p. 3519-3525
7 p.
|
artikel
|
| 129 |
One clinic visit for pre-exposure rabies vaccination (a preliminary one year study)
|
Khawplod, Pakamatz
|
|
2012
|
30 |
Supplement 3 |
p. 2918-2920
3 p.
|
artikel
|
| 130 |
One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies
|
Faenzi, Elisa
|
|
2012
|
30 |
Supplement 3 |
p. 4086-4094
9 p.
|
artikel
|
| 131 |
Parental and societal values for the risks and benefits of childhood combination vaccines
|
Gidengil, Courtney
|
|
2012
|
30 |
Supplement 3 |
p. 3445-3452
8 p.
|
artikel
|
| 132 |
Persistence of long-term immunity to hepatitis B among adolescents immunized at birth
|
Chaves, Sandra S.
|
|
2012
|
30 |
Supplement 3 |
p. 1644-1649
6 p.
|
artikel
|
| 133 |
Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulations
|
Khatami, Ameneh
|
|
2012
|
30 |
Supplement 3 |
p. 2831-2838
8 p.
|
artikel
|
| 134 |
Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: Analyses of 10 years of pertussis surveillance
|
Nilsson, Lennart
|
|
2012
|
30 |
Supplement 3 |
p. 3239-3247
9 p.
|
artikel
|
| 135 |
Phase I study of a Neisseria meningitidis liposomal vaccine containing purified outer membrane proteins and detoxified lipooligosaccharide
|
Zollinger, Wendell D.
|
|
2012
|
30 |
Supplement 3 |
p. 712-721
10 p.
|
artikel
|
| 136 |
Pneumococcal polysaccharide 23-valent vaccine: Long-term persistence of circulating antibody and immunogenicity and safety after revaccination in adults
|
Grabenstein, John D.
|
|
2012
|
30 |
Supplement 3 |
p. 4435-4444
10 p.
|
artikel
|
| 137 |
Pneumococcal vaccines WHO position paper – 2012 – Recommendations
|
WHO Publication,
|
|
2012
|
30 |
Supplement 3 |
p. 4717-4718
2 p.
|
artikel
|
| 138 |
Post-exposure immunization against Francisella tularensis membrane proteins augments protective efficacy of gentamicin in a mouse model of pneumonic tularemia
|
Sutherland, Marjorie D.
|
|
2012
|
30 |
Supplement 3 |
p. 4977-4982
6 p.
|
artikel
|
| 139 |
Potential overestimation of HPV vaccine impact due to unmasking of non-vaccine types: Quantification using a multi-type mathematical model
|
Choi, Yoon Hong
|
|
2012
|
30 |
Supplement 3 |
p. 3383-3388
6 p.
|
artikel
|
| 140 |
Potential serotype coverage of three pneumococcal conjugate vaccines against invasive pneumococcal infection in Italian children
|
Azzari, Chiara
|
|
2012
|
30 |
Supplement 3 |
p. 2701-2705
5 p.
|
artikel
|
| 141 |
Prevalence of prolonged and chronic poliovirus excretion among persons with primary immune deficiency disorders in Sri Lanka
|
de Silva, Rajiva
|
|
2012
|
30 |
Supplement 3 |
p. 7561-7565
5 p.
|
artikel
|
| 142 |
Prevalence of Streptococcus pneumoniae serotypes causing invasive and non-invasive disease in South East Asia: A review
|
Jauneikaite, E.
|
|
2012
|
30 |
Supplement 3 |
p. 3503-3514
12 p.
|
artikel
|
| 143 |
Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines
|
Monsonego, Joseph
|
|
2012
|
30 |
Supplement 3 |
p. 5215-5221
7 p.
|
artikel
|
| 144 |
Production of a conjugate vaccine for Salmonella enterica serovar Typhi from Citrobacter Vi
|
Micoli, F.
|
|
2012
|
30 |
Supplement 3 |
p. 853-861
9 p.
|
artikel
|
| 145 |
Productivity, apoptosis, and infection dynamics of influenza A/PR/8 strains and A/PR/8-based reassortants
|
Isken, B.
|
|
2012
|
30 |
Supplement 3 |
p. 5253-5261
9 p.
|
artikel
|
| 146 |
Progressive changes in pneumococcal carriage in children attending daycare in Portugal after 6 years of gradual conjugate vaccine introduction show falls in most residual vaccine serotypes but no net replacement or trends in diversity
|
Rodrigues, Fernanda
|
|
2012
|
30 |
Supplement 3 |
p. 3951-3956
6 p.
|
artikel
|
| 147 |
Prospective epidemiologic surveillance of invasive pneumococcal disease and pneumonia in children in San José, Costa Rica
|
Arguedas, Adriano
|
|
2012
|
30 |
Supplement 3 |
p. 2342-2348
7 p.
|
artikel
|
| 148 |
Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant
|
Gordon, David L.
|
|
2012
|
30 |
Supplement 3 |
p. 5407-5416
10 p.
|
artikel
|
| 149 |
Randomized placebo-controlled clinical trial of immunoglobulin Y as adjunct to standard supportive therapy for rotavirus-associated diarrhea among pediatric patients
|
Rahman, Shofiqur
|
|
2012
|
30 |
Supplement 3 |
p. 4661-4669
9 p.
|
artikel
|
| 150 |
Randomized trial of HPV4 vaccine assessing the response to HPV4 vaccine in two schedules among Peruvian female sex workers
|
Brown, Brandon
|
|
2012
|
30 |
Supplement 3 |
p. 2309-2314
6 p.
|
artikel
|
| 151 |
Rapid reduction in invasive pneumococcal disease after introduction of PCV7 into the National Immunization Plan in Israel
|
Ben-Shimol, S.
|
|
2012
|
30 |
Supplement 3 |
p. 6600-6607
8 p.
|
artikel
|
| 152 |
Reduction of high pathogenicity avian influenza virus in eggs from chickens once or twice vaccinated with an oil-emulsified inactivated H5 avian influenza vaccine
|
Swayne, David E.
|
|
2012
|
30 |
Supplement 3 |
p. 4964-4970
7 p.
|
artikel
|
| 153 |
Reframing Cervical Cancer Prevention. Expanding the Field Towards Prevention of Human Papillomavirus Infections and Related Diseases
|
Bosch, F. Xavier
|
|
2012
|
30 |
Supplement 3 |
p. F1-F11
nvt p.
|
artikel
|
| 154 |
Report of the ad-hoc consultation on aging and immunization for a future WHO research agenda on life-course immunization
|
Thomas-Crusells, Judith
|
|
2012
|
30 |
Supplement 3 |
p. 6007-6012
6 p.
|
artikel
|
| 155 |
Research priorities for global measles and rubella control and eradication
|
Goodson, James L.
|
|
2012
|
30 |
Supplement 3 |
p. 4709-4716
8 p.
|
artikel
|
| 156 |
Respiratory viruses transmission from children to adults within a household
|
MacIntyre, Chandini Raina
|
|
2012
|
30 |
Supplement 3 |
p. 3009-3014
6 p.
|
artikel
|
| 157 |
Revaccination with Fendrix® or HBVaxPro® results in better response rates than does revaccination with three doses of Engerix-B® in previous non-responders
|
Hoebe, Christian J.P.A.
|
|
2012
|
30 |
Supplement 3 |
p. 6734-6737
4 p.
|
artikel
|
| 158 |
Rotavirus vaccine series completion and adherence to vaccination schedules among infants in managed care in the United States
|
Krishnarajah, Girishanthy
|
|
2012
|
30 |
Supplement 3 |
p. 3717-3722
6 p.
|
artikel
|
| 159 |
Safety and immunogenicity of a modified process hepatitis B vaccine in healthy neonates
|
Minervini, Gianmaria
|
|
2012
|
30 |
Supplement 3 |
p. 1476-1480
5 p.
|
artikel
|
| 160 |
Safety and immunogenicity of an AS03-adjuvanted A(H1N1)pmd09 vaccine administered simultaneously or sequentially with a seasonal trivalent vaccine in adults 61 years or older: Data from two multicentre randomised trials
|
Peeters, Mathieu
|
|
2012
|
30 |
Supplement 3 |
p. 6483-6491
9 p.
|
artikel
|
| 161 |
Safety and immunogenicity of a novel nanoemulsion mucosal adjuvant W805EC combined with approved seasonal influenza antigens
|
Stanberry, L.R.
|
|
2012
|
30 |
Supplement 3 |
p. 307-316
10 p.
|
artikel
|
| 162 |
Safety and immunogenicity of a pneumococcal histidine triad protein D vaccine candidate in adults
|
Seiberling, Michael
|
|
2012
|
30 |
Supplement 3 |
p. 7455-7460
6 p.
|
artikel
|
| 163 |
Safety and immunogenicity of a vaccine targeting human papillomavirus types 6, 11, 16 and 18: A randomized, double-blind, placebo-controlled trial in Chinese males and females
|
Li, Rongcheng
|
|
2012
|
30 |
Supplement 3 |
p. 4284-4291
8 p.
|
artikel
|
| 164 |
Safety and immunogenicity of different two-dose regimens of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in healthy young adults
|
Halperin, Scott A.
|
|
2012
|
30 |
Supplement 3 |
p. 5445-5448
4 p.
|
artikel
|
| 165 |
Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq®, in Kenya, including among HIV-infected and HIV-exposed infants
|
Laserson, Kayla F.
|
|
2012
|
30 |
Supplement 3 |
p. A61-A70
nvt p.
|
artikel
|
| 166 |
Safety of Zostavax™—A cohort study in a managed care organization
|
Baxter, Roger
|
|
2012
|
30 |
Supplement 3 |
p. 6636-6641
6 p.
|
artikel
|
| 167 |
School-located influenza immunization programs: Factors important to parents and students
|
Middleman, Amy B.
|
|
2012
|
30 |
Supplement 3 |
p. 4993-4999
7 p.
|
artikel
|
| 168 |
Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa
|
Tapia, Milagritos D.
|
|
2012
|
30 |
Supplement 3 |
p. A79-A85
nvt p.
|
artikel
|
| 169 |
Seroprevalence of poliovirus antibodies amongst children in Zaria, Northern Nigeria
|
Giwa, F.J.
|
|
2012
|
30 |
Supplement 3 |
p. 6759-6765
7 p.
|
artikel
|
| 170 |
Serotype changes in adult invasive pneumococcal infections in Portugal did not reduce the high fraction of potentially vaccine preventable infections
|
Horácio, Andreia N.
|
|
2012
|
30 |
Supplement 3 |
p. 218-224
7 p.
|
artikel
|
| 171 |
Simplifying complex sequence information: A PCP-consensus protein binds antibodies against all four Dengue serotypes
|
Bowen, David M.
|
|
2012
|
30 |
Supplement 3 |
p. 6081-6087
7 p.
|
artikel
|
| 172 |
Stability of a formalin-inactivated Rift Valley fever vaccine: Evaluation of a vaccination campaign for cattle in Mozambique
|
Lagerqvist, N.
|
|
2012
|
30 |
Supplement 3 |
p. 6534-6540
7 p.
|
artikel
|
| 173 |
Streptococcus pneumoniae serotypes isolated from the middle ear fluid of Costa Rican children following introduction of the heptavalent pneumococcal conjugate vaccine into a limited population
|
Guevara, Silvia
|
|
2012
|
30 |
Supplement 3 |
p. 3857-3861
5 p.
|
artikel
|
| 174 |
Superior protection conferred by inactivated whole virus vaccine over subunit and DNA vaccines against salmonid alphavirus infection in Atlantic salmon (Salmo salar L.)
|
Xu, Cheng
|
|
2012
|
30 |
Supplement 3 |
p. 3918-3928
11 p.
|
artikel
|
| 175 |
The adjuvanticity of Chiococca alba saponins increases with the length and hydrophilicity of their sugar chains
|
Nico, Dirlei
|
|
2012
|
30 |
Supplement 3 |
p. 3169-3179
11 p.
|
artikel
|
| 176 |
The effect of an alternative reduced-dose infant schedule and a second year catch-up schedule with 7-valent pneumococcal conjugate vaccine on pneumococcal carriage: A randomized controlled trial
|
Dagan, Ron
|
|
2012
|
30 |
Supplement 3 |
p. 5132-5140
9 p.
|
artikel
|
| 177 |
The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: A meta-analysis of 8 randomized controlled studies
|
Ambrose, Christopher S.
|
|
2012
|
30 |
Supplement 3 |
p. 886-892
7 p.
|
artikel
|
| 178 |
The population based socioeconomic burden of pediatric influenza-associated hospitalization in Hong Kong
|
Chiu, Susan S.
|
|
2012
|
30 |
Supplement 3 |
p. 1895-1900
6 p.
|
artikel
|
| 179 |
The presence of viral subpopulations in an infectious bronchitis virus vaccine with differing pathogenicity – A preliminary study
|
Hewson, Kylie A.
|
|
2012
|
30 |
Supplement 3 |
p. 4190-4199
10 p.
|
artikel
|
| 180 |
The reporting completeness of a passive safety surveillance system for pandemic (H1N1) 2009 vaccines: A capture–recapture analysis
|
Huang, Wan-Ting
|
|
2012
|
30 |
Supplement 3 |
p. 2168-2172
5 p.
|
artikel
|
| 181 |
The role of nasal IgA in children vaccinated with live attenuated influenza vaccine
|
Ambrose, Christopher S.
|
|
2012
|
30 |
Supplement 3 |
p. 6794-6801
8 p.
|
artikel
|
| 182 |
The structure of HBsAg particles is not modified upon their adsorption on aluminium hydroxide gel
|
Greiner, Vanille J.
|
|
2012
|
30 |
Supplement 3 |
p. 5240-5245
6 p.
|
artikel
|
| 183 |
Three-year duration of immunity in cats vaccinated with a canarypox-vectored recombinant rabies virus vaccine
|
Jas, D.
|
|
2012
|
30 |
Supplement 3 |
p. 6991-6996
6 p.
|
artikel
|
| 184 |
Thymosin-alpha 1 (Zadaxin™) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria™) in hemodialyzed patients: A pilot study
|
Carraro, G.
|
|
2012
|
30 |
Supplement 3 |
p. 1170-1180
11 p.
|
artikel
|
| 185 |
Toll-like receptor 3 agonist complexed with cationic liposome augments vaccine-elicited antitumor immunity by enhancing TLR3–IRF3 signaling and type I interferons in dendritic cells
|
Wang, Ce
|
|
2012
|
30 |
Supplement 3 |
p. 4790-4799
10 p.
|
artikel
|
| 186 |
Towards a meningitis free world—Can we eliminate meningococcal meningitis?
|
Davie, Sue
|
|
2012
|
30 |
Supplement 3 |
p. B98-B105
nvt p.
|
artikel
|
| 187 |
Updating the Natural History of Human Papillomavirus and Anogenital Cancers
|
Moscicki, Anna-Barbara
|
|
2012
|
30 |
Supplement 3 |
p. F24-F33
nvt p.
|
artikel
|
| 188 |
Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults
|
Potsch, D.V.
|
|
2012
|
30 |
Supplement 3 |
p. 5973-5977
5 p.
|
artikel
|
| 189 |
Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix ®): Results of two randomized trials
|
Weston, Wayde M.
|
|
2012
|
30 |
Supplement 3 |
p. 1721-1728
8 p.
|
artikel
|
| 190 |
Vaccination with BM86, subolesin and akirin protective antigens for the control of tick infestations in white tailed deer and red deer
|
Carreón, Diana
|
|
2012
|
30 |
Supplement 3 |
p. 273-279
7 p.
|
artikel
|
| 191 |
Vaccination with 3-dose paediatric rotavirus vaccine (RotaTeq®): Impact on the timeliness of uptake of the primary course of DTPa vaccine
|
Wendy, Bissinger
|
|
2012
|
30 |
Supplement 3 |
p. 5293-5297
5 p.
|
artikel
|
| 192 |
Vaccine and Immunization Surveillance in Ontario (VISION) – Using linked health administrative databases to monitor vaccine safety
|
Wilson, Kumanan
|
|
2012
|
30 |
Supplement 3 |
p. 6115-6120
6 p.
|
artikel
|
| 193 |
Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010–2011: Cohort and case–control study
|
Castilla, Jesús
|
|
2012
|
30 |
Supplement 3 |
p. 195-200
6 p.
|
artikel
|
| 194 |
7-Valent pneumococcal conjugate vaccine and otitis media: Effectiveness of a 2-dose versus 3-dose primary series
|
Stoecker, Charles
|
|
2012
|
30 |
Supplement 3 |
p. 6256-6262
7 p.
|
artikel
|
| 195 |
Very small size proteoliposomes derived from Neisseria meningitidis: An effective adjuvant for antigen-specific cytotoxic T lymphocyte response stimulation under leukopenic conditions
|
Oliver, Liliana
|
|
2012
|
30 |
Supplement 3 |
p. 2963-2972
10 p.
|
artikel
|
| 196 |
Vitamin D deficiency is associated with poor response to active hepatitis B immunisation in patients with chronic kidney disease
|
Zitt, Emanuel
|
|
2012
|
30 |
Supplement 3 |
p. 931-935
5 p.
|
artikel
|
| 197 |
Yeast expressed classical swine fever E2 subunit vaccine candidate provides complete protection against lethal challenge infection and prevents horizontal virus transmission
|
Lin, Guang-Jan
|
|
2012
|
30 |
Supplement 3 |
p. 2336-2341
6 p.
|
artikel
|
Tijdschrift beschrijving